BackPliant Therapeutics Overview
Pliant Therapeutics Inc

Pliant Therapeutics Discounted Cash Flow

DCF Analysis for PLRX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.27

Current Fair Value

$0.27
76.6% Downside

Overvalued by 76.6% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading